We are live on !
Find out more
Samantha McLemore Patient Capital Management
AUM
$3.05B
Turnover
9.52%
1-Year Est. Return
42.09%
Samantha McLemore is the founder of Patient Capital Management and previously worked closely with Bill Miller on value-oriented strategies. Her firm emphasizes long-term, research-driven equity investing with a willingness to hold unconventional or out-of-favor ideas. McLemore’s portfolio is followed by investors who track the next generation of independent value managers.
This Fund
S&P 500
This Quarter Est. Return
+17.72%
1 Year Est. Return
+42.09%
3 Year Est. Return
+130.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.05B
AUM Growth
+$315M
(+12%)
Cap. Flow
-$49.6M
Cap. Flow % of AUM
Cap. Flow %
-1.63%
Top 10 Holdings %
Top 10 Hldgs %
51.37%
Holding
42
New
2
Increased
12
Reduced
24
Closed
2
Avg Time Held
Equity + Options
2.7
years
Top 10 Avg Time Held
Equity + Options
1.6
years
Top 20 Avg Time Held
Equity + Options
1.9
years
Avg Time Held Equity only
2.8
years
Top 10 Avg Time Held Equity only
1.7
years
Top 20 Avg Time Held Equity only
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Global Payments
GPN
|
+$64.9M |
| 2 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$54M |
| 3 |
Chime Financial
CHYM
|
+$23.3M |
| 4 |
Adobe
ADBE
|
+$15.1M |
| 5 |
Amazon
AMZN
|
+$6.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Noble Corp
NE
|
+$59.7M |
| 2 |
iShares Bitcoin Trust
IBIT
|
+$42.3M |
| 3 |
Illumina
ILMN
|
+$29.2M |
| 4 |
Biogen
BIIB
|
+$18.4M |
| 5 |
UBS Group
UBS
|
+$13.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.09% |
| 2 | Consumer Discretionary | 16.85% |
| 3 | Communication Services | 13.22% |
| 4 | Financials | 12.81% |
| 5 | Technology | 11.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Royalty Pharma
RPRX
$27.1B
| $202M | 6.61% |
3,598,808
-44,908
| -1% | -$2.34M |
2023 Q4
10 quarters
|
|
2
Citigroup
C
$208B
| $196M | 6.44% |
1,403,477
-10,393
| -0.7% | -$1.35M |
2022 Q1
17 quarters
|
|
3
Alphabet (Google) Class A
GOOGL
$4.17T
| $188M | 6.16% |
525,750
-8,243
| -2% | -$2.97M |
2021 Q4
18 quarters
|
|
4
UnitedHealth
UNH
$360B
| $182M | 5.96% |
437,773
+632
| +0.1% | +$234K |
2025 Q2
4 quarters
|
|
|
5
Amazon
AMZN
$2.7T
| $162M | 5.32% |
681,047
+26,628
| +4% | +$6.68M |
2021 Q4
18 quarters
|
|
6
NVIDIA
NVDA
$5.17T
| $142M | 4.65% |
709,587
-1,528
| -0.2% | -$314K |
2024 Q1
9 quarters
|
|
7
CVS Health
CVS
$118B
| $128M | 4.19% |
1,235,505
-121,654
| -9% | -$10.9M |
2023 Q3
11 quarters
|
|
8
Norwegian Cruise Line
NCLH
$6.91B
| $127M | 4.17% |
6,029,642
+280,002
| +5% | +$5.22M |
2021 Q4
18 quarters
|
|
9
QXO Inc
QXO
$11.3B
| $123M | 4.04% |
7,136,669
+358,280
| +5% | +$6.67M |
2024 Q3
7 quarters
|
|
10
Energy Transfer Partners
ET
$69.8B
| $116M | 3.81% |
6,080,678
-7,525
| -0.1% | -$146K |
2021 Q4
18 quarters
|
|
11
People Inc
PPLI
$2.89B
| $112M | 3.67% |
2,425,558
-274,006
| -10% | -$11.7M |
2023 Q2
12 quarters
|
|
12
Precigen
PGEN
$2.29B
| $109M | 3.56% |
19,036,976
+1,219,589
| +7% | +$5.27M |
2021 Q4
18 quarters
|
|
13
United Airlines
UAL
$31.2B
| $99.5M | 3.26% |
731,523
-497
| -0.1% | -$51.5K |
2022 Q2
16 quarters
|
|
14
Crocs
CROX
$5.9B
| $96.4M | 3.16% |
799,426
-43,416
| -5% | -$4.74M |
2023 Q4
10 quarters
|
|
15
Meta Platforms (Facebook)
META
$1.81T
| $96.2M | 3.15% |
170,790
-296
| -0.2% | -$181K |
2021 Q4
18 quarters
|
|
|
16
Chime Financial
CHYM
$11.2B
| $83.6M | 2.74% |
4,082,489
+1,200,473
| +42% | +$23.3M |
2025 Q4
2 quarters
|
|
|
17
Adobe
ADBE
$95.4B
| $74M | 2.43% |
361,126
+63,847
| +21% | +$15.1M |
2026 Q1
1 quarter
|
|
18
Seadrill
SDRL
$2.96B
| $73.9M | 2.42% |
1,953,355
-199,330
| -9% | -$9.28M |
2023 Q4
10 quarters
|
|
|
19
Global Payments
GPN
$22.1B
| $68.4M | 2.24% |
+942,310
| New | +$64.9M |
2026 Q2
0 quarters
|
|
20
Coinbase
COIN
$45.7B
| $67.5M | 2.21% |
462,016
+31,611
| +7% | +$5.71M |
2022 Q1
17 quarters
|
|
|
21
Fidelity Wise Origin Bitcoin Fund
FBTC
$15.1B
| $62.2M | 2.04% |
1,217,595
+863,764
| +244% | +$54M |
2024 Q1
9 quarters
|
|
|
22
Biogen
BIIB
$34.4B
| $61.3M | 2.01% |
283,697
-96,044
| -25% | -$18.4M |
2024 Q1
9 quarters
|
|
|
23
Illumina
ILMN
$39.6B
| $60.7M | 1.99% |
345,314
-199,466
| -37% | -$29.2M |
2023 Q4
10 quarters
|
|
24
General Motors
GM
$73.7B
| $48.7M | 1.6% |
631,558
-113,072
| -15% | -$8.88M |
2021 Q4
18 quarters
|
|
|
25
UBS Group
UBS
$146B
| $47.3M | 1.55% |
953,734
-288,221
| -23% | -$13.1M |
2023 Q1
13 quarters
|
|
Similar funds
CFM
Samantha McLemore's Q2 2026 Portfolio in Review
As of Q2 2026, Samantha McLemore held 42 positions worth $3.05B, up 12% from $2.74B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Samantha McLemore's Q2 2026 filing shows 2 new, 12 increased, 24 reduced and 2 closed positions. Its largest new stake was Global Payments: 942,310 shares worth $68.4M. The largest sale was Noble Corp, an estimated $59.7M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Samantha McLemore's largest Q2 2026 buy was Global Payments: 942,310 shares worth $68.4M.
- Samantha McLemore added most to Fidelity Wise Origin Bitcoin Fund in Q2 2026, an estimated $54M increase.
- Samantha McLemore's biggest Q2 2026 reduction was Noble Corp, cutting an estimated $59.7M.
- Samantha McLemore fully exited iShares Bitcoin Trust in Q2 2026, selling an estimated $42.3M.
- Samantha McLemore's ten largest holdings make up 51% of its $3.05B portfolio in Q2 2026.
- Samantha McLemore opened 2 new positions and closed 2 in Q2 2026.
- Samantha McLemore's portfolio value rose 12% quarter-over-quarter to $3.05B.
Based on Patient Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.